CureVac N.V. (LON: 0A9E)
London
· Delayed Price · Currency is GBP · Price in USD 3.940
-0.199 (-4.80%)
At close: Jan 22, 2025
CureVac Market Cap
CureVac has a market cap or net worth of 721.24 million as of January 23, 2025. Its market cap has decreased by -3.08% in one year.
Market Cap
721.24M
Enterprise Value
579.02M
Revenue
55.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.94
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 7.51B to 721.24M, a decrease of -90.39%. That is a compound annual growth rate of -40.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 753.78M | 23.37% |
| Dec 31, 2024 | 610.99M | -17.45% |
| Dec 29, 2023 | 740.11M | -22.27% |
| Dec 30, 2022 | 952.09M | -79.91% |
| Dec 31, 2021 | 4.74B | -54.77% |
| Dec 31, 2020 | 10.48B | 39.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shell | 168.73B |
| AstraZeneca | 167.37B |
| HSBC Holdings | 145.28B |
| Unilever | 113.90B |
| Rio Tinto Group | 86.42B |
| RELX PLC | 73.51B |
| BP p.l.c. | 67.77B |
| British American Tobacco p.l.c. | 65.16B |